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The life cycle of human papillomavirus type 16 (HPV16) is intimately linked to differentiation of the epithelium it infects, and late events in
the life cycle are restricted to the suprabasal layers. Here we have used 5′RACE of polyadenylated RNA isolated from differentiated W12 cells
(cervical epithelial cells containing episomal copies of the HPV16 genome) that express virus late proteins to map virus late mRNAs. Thirteen
different transcripts were identified. Extensive alternative splicing and use of two late polyadenylation sites were noted. A novel promoter located
in the long control region was detected as well as P97 and Plate. Promoters in the E4 and E5 open reading frames were active yielding transcripts
where L1 or L2 respectively are the first open reading frames. Finally, mRNAs that could encode novel proteins E6*^*E7, E6*^E4, E1^*E4 and
E1^E2C (putative repressor E2) were identified, indicating that HPV16 may encode more late proteins than previously accepted.
© 2006 Elsevier Inc. Open access under CC BY license.Keywords: Human papillomavirus type 16; Regulation of gene expression; Transcript mapping; Promoter mapping; Putative novel proteinsIntroduction
Human papillomaviruses (HPVs) infect cutaneous and
mucosal epithelia causing benign lesion, or warts, that can
sometimes progress to malignancy (Howley, 1996). A subset of
mucosal HPV types infects anogenital epithelia. Infection with
“low risk” HPV types 6 and 11 causes genital warts. However,
some other anogenital types (e.g. types 16, 18, 31) are described
as “high risk” due to the fact that persistent infections with these
cause HPV-associated lesions that can progress to cancer. Most
notably, HPV16, the most common high risk anogenital type, is
associated with 60% of cervical tumours (Walboomers et al.,
1999).
HPV16 has a 7.9 kb circular double stranded DNA genome
that exists in the nucleus of the infected epithelial cellAbbreviations: HPV, human papillomavirus; RACE, rapid amplification of
cDNA ends; mRNA, messenger RNA; LCR, long control region; 3′UTR, 3′
untranslated region; SD, splice donor; SA, splice acceptor.
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Open access under CC BY license.episomally. Episomal maintenance of the genome is essential
for completion of the virus life cycle (Stubenrauch and Laimins,
1999). The genome can be divided into an early coding region, a
late coding region and an 850 bp long control region (LCR) that
contains cis-acting regulatory sequences controlling virus
transcription and replication. Transcripts are synthesised from
only one DNA strand and are polycistronic undergoing
extensive alternative splicing and may be subject to alternative
polyadenylation (Baker and Calef, 1997). The infectious life
cycle is tightly linked to differentiation of the epithelial cell.
Early in the virus life cycle, in cells in the lower epithelial
layers, the early gene products begin to be expressed. The early
proteins include E1, E2, E6 and E7. E1 is essential for virus
genome replication. E2 is also important for replication but is
also the virus transcription regulator (zur Hausen, 2002) and is
involved in virus genome segregation during mitosis (McBride
et al., 2006). E6 and E7 interact with the tumour suppressor
proteins p53 and pRb respectively to inhibit apoptosis and
abrogate cell cycle checkpoints to allow replication of the virus
genomes in differentiated epithelial cells (Munger and Howley,
2002). E5 has been proposed to act early in infection but may
also have late functions (zur Hausen, 2002). Late proteins are
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late protein expressed, E1^E4, is detected in the spinous and
granular layers and has a number of possible functions late in
infection (Doorbar et al., 1997). Expression of L1 and L2, the
virus capsid proteins, is restricted to cells of the granular layer.
This situation may aid immune evasion as these proteins are
highly immunogenic. However, L1 and L2 RNAs can be
detected in lower epithelial layers (Crum et al., 1988; Stoler et
al., 1989) indicating that regulation of protein expression is
post-transcriptional, likely at the level of nuclear retention and
RNA decay (Koffa et al., 2000; Kennedy et al., 1991).
There have been many studies designed to map HPV
transcripts. Some of these used cervical tumour cell lines
where the virus life cycle has been disrupted and the late genes
are not expressed (Schwarz et al., 1985; Schneider-Gädicke and
Schwarz, 1986; Baker and Howley, 1987; Sherman et al., 1992).
Other elegant early studies using electron microscope R-loop
mapping mapped the main transcripts arising in HPV1, 6 and 11
infected tissue (Chow et al., 1987a, Palermo-Dilts et al., 1990;
Chow et al., 1987b). However, RNA was prepared from whole
warts. Thus, no distinction could be made between early and late
mRNAs expressed in the lower and upper epithelial layers
respectively. One study using in situ hybridisation of HPV16
precancerous lesions detected a number of late RNAs but these
were not precisely mapped (Crum et al., 1988). More recently,
studies of HPV31 used CIN612 9E cells that were derived from a
low-grade cervical lesion induced to differentiate in semisolid
medium (Meyers et al., 1992; Ruesch et al., 1998). This gives a
large population of differentiated cells that can be used to study
late RNAs. The first study isolated polyadenylated RNA and
defined the structure of six major early region mRNAs and three
late mRNAs, two encoding L1 and L2 (Hummel et al., 1992;
Hummel et al., 1995). Another study examined RNAs produced
in CIN612 9E organotypic raft cultures induced to differentiate
by treatment with phorbol esters (Ozbun and Meyers, 1997).
Nineteen different transcripts were identified that encoded at
least the L1 capsid protein indicating that these represented the
HPV31 late transcript population. However, RT-PCR analysis
was carried out on total RNA so it is not possible to be certain
that all these RNAs exist as protein-coding messenger RNAs at
steady state levels in the infected cell.
Previously there have been only two studies of the transcripts
synthesised by the HPV16 genome during the virus life cycle,
one in KG cells (HPV16-positive vulvar intraepithelial
neoplasm cell line) (Grassman et al., 1996) and one in the
W12 cell line (Doorbar et al., 1990). The W12 cell line was
established from cervical epithelial cells taken from a patient
with a low-grade cervical lesion (Stanley et al., 1989). The cells
are immortalised but not transformed and maintain up to 1000
episomal copies of the HPV16 genome in the differentiated cells
(Jeon et al., 1995; Garner-Hamrick and Fisher, 2002). Most
importantly, they can be induced to differentiate in monolayer
culture by a number of means including culturing to high
density in 1.2 mM Ca2+. In the W12 study, total RNA was
extracted from cells grown in the absence of calcium but to high
density. The differentiation status of the cells from which RNA
was prepared was not determined. However, a number of RNAsencoding E6, E7, E1^E4, E5 and L1 were identified and the
major splice donor and splice acceptor sites of the virus genome
were mapped (Doorbar et al., 1990). In the KG study,
polyadenylated RNA was isolated from raft cultures (a mix of
undifferentiated and differentiated cells) of KG cells. Similar
RNAs to some of those found in the W12 study were delineated
and some of the splice donor/acceptor sites confirmed (Grass-
man et al., 1996). Neither of these studies set out to map
specifically and exhaustively the HPV16 late mRNA population
because the RNA populations examined were likely a mix of
early and late transcripts.
Here we have used W12 cells differentiated in monolayer
culture that express markers of epithelial differentiation
(involucrin, filaggrin) and the virus late proteins E1^E4 and
L1, and 5′RACE, together with primer extension to carry out a
complete analysis of the mRNAs synthesised from the HPV16
genome. The advantage of using RACE as opposed to 5′RT-
PCR is that the 5′ primer used does not define the 5′ ends of the
mRNAs. In theory therefore, a full array of mRNAs with
known, and undiscovered, 5′ ends can be examined. We have
delineated thirteen mRNAs expressed late in the HPV16 life
cycle and show two distinct transcript populations, one
encoding L1 alone and the other encoding L1 and L2.
Previously observed splice donor and splice acceptor sites are
confirmed and other novel sites characterised. We report
extensive use of the PE4 promoter that transcribes a mono-
cistronic RNA encoding only L1 and frequent use of the Plate
promoter where initiation is imprecise, covering a region of
around 200 nucleotides within the E7 gene. We present
evidence for a novel promoter located 157 nucleotides upstream
of P97 in the long coding region and one located in the E5 open
reading frame. Finally, we have detected novel HPV16 RNAs
that may encode E6*^*E7, E1^E2C, E6*^E4, and E1^*E4,
indicating that at late times of HPV infection there may be more
proteins expressed than was previously considered.
Results
The W12 cell line differentiates efficiently and expresses late
proteins
The W12 cell line is a good model for study of the HPV16
life cycle because the cells contain many episomal copies of the
HPV16 genome and can be induced to differentiate in
monolayer culture (Jeon et al., 1995) to express markers of
epithelial differentiation and virus late proteins (McPhillips
et al., 2004). In order to ensure maintenance of the virus
genomes as episomes (to abrogate integration into the host
genome) and to obtain good differentiation, the cell line was
used at low passage (<17 passages). We checked routinely that
the majority of genomes in the cells we cultured were episomal.
On average greater than 90% of genomes remain episomal at
passage 17. When the cells are cultured for up to 5 days in low
concentrations of calcium at low density (<30% confluent, few
colonies), only very low levels of involucrin, a marker of
suprabasal epithelial cells, are detected and expression of the
first virus late protein E1^E4 is also low (Fig. 1). However,
Fig. 1. Differentiation of W12 cells populations. Immunofluorescence analysis of undifferentiated and differentiated W12 cells demonstrating expression of virus late
proteins L1 and E1^E4. Nuclei are DAPI-stained. Although cells were grown at different confluence, they were plated out onto coverslips at similar density 16 h prior
to fixation for microscopy.
Fig. 2. Northern blot analysis of expression of late transcripts in undifferentiated
(U) and differentiated (D) W12 cells. Radiolabelled probes were either the insert
from plasmid pRL1 containing a portion of the L1 gene (nts 6151–6818) or the
insert from plasmid pE4 containing the entire E4 gene sequence (nts 3339–
3598) (E4). Total; total cellular RNA. poly(A)+; polyadenylated RNA. Blots
were hybridised in 50% formamide 5× SSC at 42 °C for 16 h and washed to 0.1×
SSC at 65 °C. Blots were stripped and reprobed with radiolabelled actin or
GAPDH sequences as loading controls.
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over 70% confluence, between 75 and 85% of the population
express involucrin indicating that most cells are differentiated.
In addition, around 80% of cells express E1^E4 and around 5%
of cells strongly express L1, the major capsid protein (Fig. 1). In
Fig. 1, although cells labelled as undifferentiated were cultured
at 30% confluence to inhibit differentiation, they were plated
onto coverslips 16 h before fixing for microscopy at an
equivalent density to differentiated W12 cells. The low level of
involucrin staining in the undifferentiated population indicates
that this procedure did not induce significant differentiation of
these cells.
“Undifferentiated” W12 cell RNA was prepared from
populations of cells that expressed very low levels of involucrin
or E1^E4, as assayed byWestern blotting, while “differentiated”
W12 cell RNA was prepared from cell populations that
expressed high levels of involucrin and E1^E4 and showed
some L1 expression. Northern blot analysis of DNase 1-digested
total RNA indicated that RNAs encoding L1 were equally as
abundant in undifferentiated as in differentiated W12 cells
(Fig. 2A). Late transcripts detected were similar in size to those
detected previously in L18 (HPV18-positive; Frattini et al.,
1997) and CIN612 9E (HPV31-positive; Ozbun and Meyers,
1997; Klumpp and Laimins, 1999) cells. However, analysis of
polyadenylated RNAs indicated that fully processed L1-
encoding mRNAs were present only in differentiated W12
cells (Fig. 2B). A range of sizes of mRNAs from around 0.8–
2 kb was detected as expected. Hybridisation of a similar
Northern blot with an L2 probe failed to detect any L2-encoding
mRNAs, although this probe did detect transcripts in the total
Fig. 3. Polyadenylation of HPV16 late transcripts in vivo. (A) Agarose gel
electrophoresis of products of 3′RACE using nested L1 gene-specific primers
and cDNA reverse transcribed from polyadenylated W12 cell RNA. Track 1:
DNA, marker track 2: undifferentiated RNAwithout reverse transcriptase, track
3: differentiated RNA without reverse transcriptase, track 4: undifferentiated
RNA with reverse transcriptase, track 5: differentiated RNA with reverse
transcriptase. The arrowhead indicates the major product corresponding to
polyadenylation at LP2 and the arrow a minor product indicating polyadenyla-
tion at LP1. (B) Diagram of the HPV16 genome showing the approximate
positions of the early and late polyadenylation sites. Below is shown the region
of genome sequence from 7251 to 7350 containing the two active late
polyadenylation sites. Grey boxes indicate the polyadenylation signals.
Arrowheads indicate the cleavage sites.
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with an E1^E4 probe gave a similar pattern of transcripts
(Fig. 2C), confirming that E1^E4 is encoded in a polycistronic
RNAwith L1. Again hybridisation to polyadenylated RNAwas
only in the differentiated cell population (Fig. 2D).
3′RACE reveals use in vivo of two late polyadenylation sites
upon epithelial differentiation
All late transcripts are predicted to co-terminate in the late 3′
UTR. Therefore, 3′RACEwith nested primers located at the end
of the L1 coding region (Table 1) was used to map the 3′ ends of
the late mRNAs present in undifferentiated and differentiated
W12 cells. No major products were amplified from cDNA
reverse transcribed from polyadenylated RNA isolated from
undifferentiated W12 cells (Fig. 3A, lane 4). In contrast, a major
band of around 350 bp and a minor band of around 270 bp were
PCR-amplified from differentiated W12 cells (Fig. 3A, lane 5).
Sequence analysis of 40 cloned cDNA products from each band
showed that the upper band represented use of the LP2 cleavage
site at nt 7343 (AAUAAA at nt 7319) (Fig. 3B), while the
smaller band represented use of the proximal LP1 cleavage site
at nt 7284 (AAUAAA at nt 7260, 58 nucleotides upstream of
the LP2 site). No products were obtained when reverse
transcriptase was omitted from the initial reverse transcription
reactions (Fig. 3A lanes 2 and 3). The results of these
experiments indicate that both the LP1 and LP2 sites can be
used in vivo in late transcripts in differentiated infected
epithelial cells and that few full-length polyadenylated late
transcripts are present in undifferentiated W12 cells. A
polyadenylation signal in the L1 coding region active in HeLa
cells transfected with an L1 expression construct was describedTable 1
Oligonucleotides used in this study
5′RACE
L1 6069 (RT) CTCTATTATCCACACCTGCAT
LI 5968 TGACCACGACCTACCTCAACACCTACACA
L1 5776 TGTCCAACTGCAAGTAGTCTGGATGTTCCT
LI 5690 TACTGGGACAGGAGGCAAGTAGACAGTGGCCTCAC
L2 4506 GGTCTTACAGGAGCAAGTGTATCTGTAGCT
L2 4456 TGGAATATACCCAGTGCGTCCGCCTGTA
E5 3890 GCACGCCAGTAATGTTGTGGATGC
E2 3845 GACATAAATCCAGTAGACACTGTAAT
E4 3596 CAGTTAATCCGTCCTTTGTGTGAGCT
E4 3451 CTTCGGTGCCCAAGGCGACGGCTTTGGTAT
3′RACE
Outer primer
7004
CTGCAGACCTAGATCAGTTTC
Inner primer
7047
CAAGCAGGATTGAAGGCC
Primer X 5746 CCAGACTACTTGCAGTTGGAC
Primer Y 5948 TGTTGAGGTAGGTCGTGGTCAGC
Primer extension
E6 222 CGTCGCAGTAACTGTTGCTTGCAGTACAC
E7 766 CGCACAACCGAAGCGTAGAGTCACAC
E1 979 CGTTCTCGTCATCTGATATAGCATCCC
E4 3412 CGGGGTGGTTGGCCAAGTGCTGCC
E5 4126 GTAACAATTACATTATGTACATATACATTATGpreviously (Öberg et al., 2003). 3′RACE using primers X and Y
in Table 1 failed to detect use of this site in differentiated W12
cells (data not shown).
5′RACE detection of late transcripts synthesised in
differentiated W12 cells
cDNAs representing W12 cell late mRNAs were amplified
from DNase I-treated polyadenylated RNA isolated from
differentiated W12 cells using a primer located within the L1
coding region (5′ nt 6069, Table 1). C-residues were added to the
5′ end of the cDNAs using terminal deoxynucleotidyl
transferase. A 5′RACE amplification primer (AP, Invitrogen)
containing G- and I-residues to prime specifically from the
added 5′ C-tail and one of the nested upstream L1 PCR primers
(5′ nts 5968, 5776, 5690, Table 1) or L2 primers (5′ nts 4506,
4456, Table 1) was used to PCR-amplify the cDNAs. To be sure
that full-length mRNAs were mapped, a genome walk was
accomplished using cDNA synthesis with a series of primers
located in the E5, 3′ E2 and E4 open reading frames. PCR
amplification with nested 3′ primers (Table 1) and the AP 5′
RACE primer was carried out. Each reaction was designed to
yield populations of products that overlapped with a separate
Fig. 4. Schematic diagram of the transcripts identified by 5′RACE. (A) A diagram of the linearised virus genome. Open boxes; coding regions, arrows; promoter
positions, chevrons; approximate positions of the primers used in 5′RACE. Early poly(A) and vertical bar: early polyadenylation site, late poly(A) and vertical bars:
late polyadenylation sites. (B) Structures of the cDNA species identified. Grey bars: coding sequences, lines: introns spliced out. Numbers indicate the genomic
positions of the 5′ ends of the cDNAs and the splice donor and acceptor sites.
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reading frame as we were interested in late mRNAs. Transcripts
encoding E1 and E2 are present late in the virus life cycle, but
these terminate at the early polyadenylation site (data not
shown). The strategy is diagrammed in Fig. 4A. PCR products
were amplified and cloned into pGEM T-easy vector. Recombi-
nant plasmid DNA was isolated from bacterial colonies, and at
least 10 clones from each PCR reaction were sequenced.Table 2
Splice donor and acceptor sites used in mRNAs synthesised in differentiated W12
cells
Consensus splice acceptor and donor sites are indicated at the top in brackets.
* Novel splice sites identified in this study. Arrowheads indicate splice junctions.Structures of mRNAs were carefully checked by comparing
sequences obtained from different PCR amplification reactions
and by PCR amplification across splice junctions. Thirteen main
transcript types were obtained (Fig. 4B). These could be divided
into two classes, those that encoded L1 (in some cases with other
open reading frames) and those that encoded both L1 and L2 (in
some cases with other open reading frames). Splice donor and
acceptor sites are shown in Table 2. Several mRNAs have the
capacity to encode novel chimeric proteins (Table 3).
Promoters in the E4 and E5 reading frames are used to express
late transcripts
Two of the mRNAs identified appeared to have their 5′ ends
at the start of the E4 open reading frame and one at the end of
the E5 open reading frame. Promoters within E4 have been
reported previously (Doorbar et al., 1990; Ozbun and Meyers,Table 3
Putative novel proteins encoded by the W12 HPV16 genome
Transcript no. Coordinates Putative protein Size (aa)
2 P97 promoter E6*^E4 48
SA: 226 SD: 3357
3 P97 promoter E1^E4* 81
SA: 880 SD: 3390
10 Promoter unmapped E1^E2C 177
SA: 1302 SD: 3357
11 P97 promoter E6*^E7* 53
SA: 226 SD: 743
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before the 5′ end of the transcript was reached, it was possible
that the products we identified were representative of
incomplete cDNAs. So primer extension was used to identify
transcription start sites for the late mRNAs using primers that
would be expected to be sited around 100 nucleotides
downstream of the putative promoters predicted from the
RACE analysis (Fig. 4A). Total RNA was isolated from
differentiated W12 cells and from differentiated HaCaT cells as
a virus-negative epithelial cell control. Each primer extension
was repeated at least five times, and sequencing ladders were
run on the gels, as well as the size markers shown, to accurately
size the observed products. Figs. 5A and B tracks 2 show a
major product of around 130 nucleotides for PE6 and around 97
nucleotides for PE7. These correspond to transcription starts at
P97 and P696, in agreement with the positions of known HPV16
promoters (Smotkin and Wettstein, 1986; Doorbar et al., 1990;
Grassman et al., 1996). A longer exposure of the E7 primer
extension gel shows a number of subsidiary start sites over 100
nucleotides from around genome position 650 to 760 (Fig. 5E).
A discrete band of 105 nucleotides, corresponding to a
transcription start site at P3392, was observed using a primer
within the E4 gene region (Fig. 5C) that corresponded to the
predicted PE4 promoter previously observed for HPV31 (Ozbun
and Meyers, 1997). Finally, two products at 86 and 84
nucleotides corresponding to a transcription start at P4062/4064
were observed when a primer within the E5 gene region was
used (Fig. 5D), confirming the RACE data that indicated the
presence of a promoter at the end of the E5 open reading frame.
No primer extension products for the E6, E7, E4 and E5 primers
were detected with HaCaT RNA as the starting material.
Transcripts 10 appeared to start within the E1 open reading
frame. As a similar transcription start had previously been
identified in HPV1, it was expected that primer extension would
also verify this promoter. However, no bands exclusivelyFig. 5. Primer extension mapping of the transcription start sites of the W12
RNAs. Tracks 1: Century RNA marker (Ambion), 2: W12 RNA, 3: HaCaT
RNA. Arrows indicate the major transcript starts. Stars indicate minor transcript
starts. Oligonucleotide probes used are indicated below the autoradiographs.present in W12 cell tracks were identified. Transcripts 4
indicated the presence of a promoter in the LCR, but this could
not be confirmed by primer extension indicating that transcrip-
tion initiation from this promoter may be infrequent.
Discussion
Here we report a thorough analysis of thirteen HPV16
mRNAs synthesised in differentiated W12 cells grown in
monolayer. Although the monolayer population is mixed with
respect to differentiation status, we estimate that between 75 and
85% of the population express involucrin, a marker of
suprabasal epithelial cells, and E1^E4, the first virus late protein
expressed during the HPV16 life cycle (Doorbar et al., 1997).
Only around 5% of cells express the major capsid protein but by
Northern blotting we have demonstrated that mRNAs encoding
at least the L1 capsid protein are abundant in these cells. This
means that the majority of cells within the population clearly
support significant late events in the virus life cycle and that we
have analysed HPV16 late mRNAs. L2 probes failed to detect
L2-encoding mRNAs by Northern blot, but these were present
in the late mRNA population as they were readily amplified by
RACE. This may indicate that L2 mRNAs are present at a low
level in the late RNA population in HPV16-infected cells per-
haps reflecting the much lower requirement for L2 in capsid
formation. Northern blotting also confirmed that HPV16 late
gene expression is regulated post-transcriptionally because
abundant RNAs encoding E4 and L1 were observed in RNA
prepared from largely undifferentiated cells, but no polyadeny-
lated E4 or L1 mRNAs were detected in this cell population.
This indicates that the RNAs detected in the total RNA popula-
tion are nonpolyadenylated and would therefore be unstable.
Northern blotting of undifferentiated HPV31 total RNAs has
also revealed long polycistronic transcripts of similar size to
those observed in this study, indicating that this regulation is not
specific to HPV16 (Klumpp and Laimins, 1999).
The first characterisation of mRNAs encoded by HPV16 in
W12 cells was carried out on a mixed population of
undifferentiated and differentiated W12 cells using defined 5′
and 3′ primers (Doorbar et al., 1990). This strategy would
restrict the mRNAs found to those containing binding sites for
those primers. In contrast, we have used a 3′ reverse
transcriptase primer that should be present in all late mRNAs
because they are predicted to end in the late 3′UTR. More
importantly, we have not used a defined 5′ primer but have 5′
anchor primer-C-tailed the cDNAs synthesised and used the
anchor primer as the subsequent 5′ primer. In the Doorbar study,
four of the mRNAs described were clearly early region
transcripts as they did not contain the late coding region. We
have not yet identified the two late mRNAs they described.
Ozbun and Meyers (1997) described a complex set of
transcripts synthesised in organotypic raft cultures (treated
with the protein kinase activator, C8:0) established from
CIN612 9E cells containing episomal HPV31 genomes. The
use of raft cultures ensured identification of a population of late
transcripts. However, the cell population also contained
undifferentiated cells and total RNA was used as the starting
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transcripts identified may be expressed early in the life cycle
and some may be unprocessed or partially processed RNAs. We
used polyadenylated RNA as the substrate for cDNA synthesis
in the present study so it is very likely that the transcripts we
have analysed are fully processed.
We have identified a panoply of putative promoters
approaching the complexity of what has been described for
BPV1 (Baker and Howley, 1987). As expected, transcripts that
use the well-characterised P97 promoter were found underlining
the constitutively active nature of this promoter (Smotkin and
Wettstein, 1986; Smotkin et al., 1989; Doorbar et al., 1990;
Grassman et al., 1996). A series of transcription starts in the E7
open reading frame was identified. The major band detected in
primer extension gave a start site of P696 and transcripts 5 and 9
had their 5′ ends at this position. This is 27 nucleotides
downstream from the start site detected in KG cells (Grassman
et al., 1996). However, the KG cell study used only primer
extension to map the 5′ ends of HPV16 transcripts, whereas we
have combined data from primer extension and 5′RACE, which
may give a more accurate estimate. The start sites we detected
covered a large region around this site, in agreement with
previous studies on HPV31 (del Mar Pena and Laimins, 2001).
Imprecise transcription initiation is known to occur frequently
for non-TATA, non-initiator promoters (Smale, 1997), and it is
likely that the E7 promoter falls into this class. There has been a
report of a promoter in the E6 open reading frame at nucleotide
542 that is active in SiHa cells but is predicted to be
differentiation-dependent and thus also active during the
HPV16 life cycle (Glahder et al., 2003). We did not identify
this transcription start site. However, if transcription initiation
was imprecise on this TATA-less promoter, it may be the
promoter for transcripts 8 in Fig. 4. Transcripts 10 indicated use
of a promoter in the E1 open reading frame. An E1 promoter has
been reported for BPV1 (Choe et al., 1989). Transcripts 10
displayed an extremely good consensus splice donor site at
nucleotide 1302 with splicing to the E4 splice acceptor site, as
previously noted (Doorbar et al., 1990). These mRNAs would
putatively encode up to 50 amino acids from the 5′ end of E1
spliced on to the E2 open reading frame generating an E8^E2C
protein and/or a novel E1^E4 product. Unfortunately, we could
not prove use of the E1 promoter in the primer extension
experiments. Doorbar et al. (1990) first identified a putative
promoter in the E4 open reading frame. Later a similarly
positioned promoter was shown to be used for production of late
transcripts in HPV31 (Ozbun and Meyers, 1997). Our data
indicate that this promoter, which initiates transcription at
nucleotide 3397, is used relatively frequently as many cDNAs
with the structure shown for transcript 7 were identified from
sequencing of the products of 5′RACE. The predicted size of a
transcript initiating at nucleotide 3397 with splicing at 3631 at
the 3′ end of the E4 open reading frame to 5637 at the 5′ end of
the L1 coding region and terminating at the major late
polyadenylation site is 1858 bases. It is likely that the lower
band in the E4 Northern blot of polyadenylated RNA in Fig. 2 is
this mRNA. The stronger intensity upper bands of around 2 kb
may be a mixture of transcripts 2–6. Comparison of primerextension and Northern blot data indicates that the PE4 promoter
is less active than the Plate promoter overall. A promoter at the 3′
end of the E5 coding region has previously been described for
BPV1 (Baker and Howley, 1987), HPV1 (Chow et al., 1987a,
Chow et al., 1987b), HPV6b (Karlsen et al., 1996) and HPV16
and 18 (Rohlfs et al., 1991; Geisen and Kahn, 1996), but not for
HPV11 or 31. Primer extension analysis confirmed the 5′RACE
mapping showing transcripts that started at 4062/4064 with L2
as the first open reading frame. cDNA clones whose 5′ ends
mapped to P4062/4 were relatively abundant and primer
extension gave a band of higher intensity than that for P97
initiated transcripts suggesting that this initiation site was used
frequently. However, because an L2 probe failed to detect
mRNAs in Northern blots, possibly due to instability elements
in the L2 open reading frame (Öberg et al., 2003), it is difficult
to really assess how frequently this promoter is used. Finally,
transcripts 4 were initiated from a promoter in the long control
region. Promoters such as this have been described previously
for HPV31 (Ozbun and Meyers, 1999) and BPV1 (Baker and
Howley, 1987) but we did not observe a band corresponding to
this initiation site in primer extension.
As expected, the W12 HPV16 late mRNAs were the
products of extensive alternative splicing and also alternative
polyadenylation. Most of the 5′ and 3′ splice sites we mapped
agree with those mapped previously for HPV16 (Doorbar et al.,
1990; Baker and Calef, 1997; Zhao et al., 2005) and correspond
to those mapped for HPV31 (Ozbun and Meyers, 1997). We
confirm a splice acceptor site in the E7 open reading frame at
nucleotide 743, previously mapped in cervical cancer cells
(Tang et al., 2006), indicating that production of this E6^E7
mRNA is not a tumour-specific splicing event. A new good
consensus splice acceptor site at 3390 in the E4 open reading
frame (transcript 3) was found. Use of this splice site putatively
trims 11 amino acids from the 5′ end of the E4 portion of the
E1^E4 protein. A number of transcripts (transcripts 9) were
detected where a novel splice variant was observed indicating
the presence of a very small intron at the end of the E2 open
reading frame. The putative splice acceptor site is good
consensus, but the splice donor site is poor (Table 2). This
product could be a sequencing artefact, however, many
transcripts displaying this putative intron were identified. If
this splice event occurred, it would remove 11 amino acids in
frame from the DNA binding/dimerisation domain of E2. There
are three putative late polyadenylation sites at nucleotides 7285,
7343 and approximately 7680. Kennedy et al. (1990) reported
the use in vitro of the first, a putative weak polyadenylation site,
and the last, a putative strong polyadenylation site. We now
demonstrate use in vivo of these two sites and confirm that site
7285 is used less frequently. It is unclear as yet whether
different transcripts use one or other of these.
Table 3 describes four mRNAs that have the potential to
encode novel short virus proteins. This raises the possibility that
HPV16 encodes more proteins than previously considered. If
so, this could extend the regulatory networks by which the virus
controls host cell function. Verification of the existence of these
in patient tissue is ongoing. Ultimately expression of proteins
from these mRNAs requires to be demonstrated but this may
179S.G. Milligan et al. / Virology 360 (2007) 172–181prove difficult due to the expected low abundance of viral
proteins in infected tissue.
Finally, these analyses begin to indicate how it is possible that
the L1 and L2 proteins are efficiently translated from late
transcripts. Previously, focus was on the well-characterised P97
and Plate promoters and all late mRNAs were assumed to be
polycistronic. The laws of translation initiation would indicate
very inefficient expression of the late proteins as they are
encoded by subsequent open reading frames (Kozak, 1991).
Transcripts 7 are abundant mRNAs that have L1 as the first open
reading frame meaning that translation of this protein from these
transcripts would be efficient. Transcripts 13 are initiated from a
promoter at the 3′ end of the E5 open reading frame, and thus L2
is the first open reading frame in these mRNAs. E1^E4 and E5
are also now considered as late proteins. Transcripts 5 and 6
have E1^E4 as the first open reading frame while transcripts 12
encode E5 first. The considerable diversity of promoters used
and the transcripts they initiate may allow efficient translation of
proteins from mRNAs that are polycistronic in nature due to the
compact organisation of the HPV genome.
Materials and methods
Cell culture
The 20863 (W12E) cell line is a subclone of the W12 line, an
HPV16 positive cell line derived from a low-grade cervical
lesion, which contains, depending on the differentiation state of
the cells, up to 1000 episomal copies of the HPV16 genome
(Stanley et al., 1989; Jeon et al., 1995). For monolayer culture,
W12E cells were co-cultured with mitomycin C-treated J2 3T3
fibroblast feeder cells at a ratio of 1:5, seeding W12E cells at
2×105 cells/100mm dish (Jeon et al., 1995). TheW12E line was
grown for up to 5 days for undifferentiated cells (cells at around
30% confluence, no colonies), and 10 days for differentiated
cells (large colonies of W12 cells), respectively. HaCaT cells,
spontaneously immortalised keratinocytes (Boukamp et al.,
1988), were grown in DMEM, 10% foetal calf serum and 2 mM
glutamine. Cells remained undifferentiated at 30% confluence
and were differentiated at around 70% confluence after growing
for 6 days.
Plasmids
pRL1 was a gift of Dr. Craig Meyers, Penn State University
Medical School. It contains a BamHI/EcoRI fragment (nts
6151–6818). pE4 was prepared by PCR amplification of the E4
gene sequence, from the W12 genome cloned into pBluescript
(pEF2), using sense primer nt 3339 5′ GTCCTACATCTGTGT-
TTAGCAGC 3′ and antisense primer nt 3598 5′ CAGTTAA-
TCCGTCCTTTGTGTGAGC 3′ and cloning into pGEM-Teasy
vector (Promega).
Immunofluorescence microscopy
W12 cells were grown in the presence of 3T3 feeder cells
for 4 days (for undifferentiated cell populations) or 9 days (fordifferentiated cell populations) in 100 mm culture dishes. At
day 4 or day 9, 3T3 cells were removed by trypsinisation and
W12 cells at 2×105 cells per coverslip were grown overnight
on sterile 18×18 mm coverslips in keratinocyte growth
medium (Cambrex Bioscience, UK). Cells on coverslips
were washed three times with PBS and fixed in 20% sucrose,
5% formaldehyde in PBS for 10 min at room temperature.
After three washes with PBS, the coverslips were permeabi-
lised with 70% acetone, 30% methanol solution for 5 min at
−20 °C then washed three times with PBS and incubated in
PBS containing 20% normal calf serum for 1 h at room
temperature. Cells were incubated with primary antibodies
diluted in 1% calf serum in PBS for 1 h at room temperature.
Involucrin antibody (SY5, Sigma) was used at 1:1000, E1^E4
(TGV 402, (Doorbar et al., 1988)) and L1 (K1H8, Dako) at
1:50. Coverslips were washed in PBS six times before
incubation for 1 h with fluorescein-labelled anti-mouse
secondary antibody diluted 1:1000 in 1% (v/v) calf serum in
PBS (Vector Laboratories). After washing in PBS six times,
the coverslips were mounted with Vectashield mounting
medium (with DAPI as a nuclear stain). Images were taken
using a Zeiss LSM510 Meta confocal microscope.
RNA preparation
Following removal of the 3T3 feeder cells by trypsinising,
total RNA was extracted from W12 cells using Trizol reagent
(Invitrogen) according to the manufacturer's instructions.
Polyadenylated RNA was prepared by two passages of the
RNA through an oligotex column using the mRNA mini kit
(Qiagen) according to the manufacturer's instructions. RNA
was checked for integrity by Northern blotting using a
radiolabelled actin probe.
Northern blotting
10 μg total RNA or 0.5 μg polyadenylated RNA was
fractionated on a denaturing 1.2% agarose–2.2 M formaldehyde
gel and Northern blotted onto Hybond-H (Amersham) as
described (Sambrook et al., 1989). Blots were hybridised with
[32P]-labelled DNA probes synthesised by random priming in
5× SSC (1× SSC is 0.15 M sodium citrate)–50% formamide at
55 °C for 16 h and washed to 0.1× SSC at 65 °C followed by
autoradiography.
5′RACE
Polyadenylated differentiated W12 cell RNA was DNase I-
treated for 1 h at 37 °C using RQ DNase I (Promega) according
to the manufacturer's instructions. cDNAwas synthesised using
L1 RT 6069 primer (Table 1) and Superscript II reverse
transcriptase (Invitrogen) at 42 °C for 1 h. Input RNA was
removed by treatment with RNase H at 37 °C for 30 min. cDNA
was purified using a Qiagen PCR purification kit according to
the manufacturer's instructions. cDNA was 5′ end C-tailed
using terminal deoxynucleotidyl transferase (Invitrogen). PCRs
were carried out using 5′RACE abridged anchor primer
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located upstream of the primer used in the reverse transcription
reaction. Subsequent PCR reactions used abridged universal
amplification primer (Invitrogen) with internal 3′ primers. PCR
products were fractionated on agarose gels, and bands were
excised and purified using a Qiaquik gel extraction kit (Qiagen).
Where products were less that 500 nucleotides, fractionation
was on 6% acrylamide gels. DNA was eluted from excised
bands from acrylamide gels by incubation overnight at 4 °C in
0.5 M NaCl, 1 mM EDTA pH 8.0. DNA was recovered by
ethanol precipitation. Purified DNA was ligated into pGEM-
Teasy vector (Promega) and transformed into XL-10 super-
competent E. coli cells (Stratagene). Recombinant plasmid-
containing bacteria were purified and inserted DNA was
sequenced.
3′RACE
RNA preparation, DNase I treatment and reverse transcrip-
tion were exactly as for 5′RACE except oligo(dT) was used to
prime first strand cDNA synthesis. 3′RACE was carried out
according to the manufacturer's protocol (Invitrogen). For
amplification of endogenous late transcripts in W12 cells, two
gene-specific 5′ primers, outer primer 7004 and inner primer
7049 (Table 1), were used with the 3′ universal amplification
primer (Invitrogen). To search for transcripts with 3′ end in the
L1 open reading frame, gene-specific primers X and Y were
used.
Primer extension
DNA oligonucleotides probes were end-labelled by filling in
of recessed 3′ termini. 300,000 cpm of probe was ethanol
precipitated with 15 μg total RNA. The precipitated nucleic
acids were resuspended in 30 μl hybridisation buffer (40 mM
PIPES pH 6.4, 1 mM EDTA pH 8.0, 0.4 M NaCl, 80%
formamide). The hybridisation mix was incubated at 85 °C for
10 min to denature the nucleic acids. Hybridisation was carried
out at the desired annealing temperature overnight. Following
overnight incubation, the hybrids were ethanol precipitated and
resuspended in 20 μl reverse transcriptase buffer (50 mM Tris–
HCl pH 7.6, 60 mM KCl, 10 mM MgCl2, 1 mM dNTPs, 1 mM
DTT, 1 unit RNasin (Promega)). Fifty units of Superscript II
(Invitrogen) was added and the reaction incubated for 1 h at
42 °C. The template was removed by addition of EDTA to
25 mM and DNase-free RNase to 0.25 μg/ml and incubation at
37 °C for 30 min. The mixture was then phenol/chloroform
extracted and ethanol precipitated. The washed pellet was
dissolved in 6 μl formamide loading buffer and the products
denatured by heating at 95 °C for 5 min and resolved by
electrophoresis through a 6% denaturing polyacrylamide/urea
gel.
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